Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
BACKGROUND: As a subclass of noncoding RNAs, circular RNAs (circRNAs) have been demonstrated to play a critical role in regulating gene expression in eukaryotes. Recent studies have revealed the pivotal functions of circRNAs in cancer progression. However, little is known about the role of circTADA2A, also named hsa_circ_0043278, in osteosarcoma (OS). METHODS: CircTADA2A was selected from a previously reported circRNA microarray comparing OS cell lines and normal bone cells. QRT-PCR was used to detect the expression of circTADA2A in OS tissue and cell lines. Luciferase reporter, RNA immunoprecipitation (RIP), RNA pull-down and fluorescence in situ hybridization (FISH) assays were performed to confirm the binding of circTADA2A with miR-203a-3p. OS cells were stably transfected with lentiviruses, and Transwell migration, Matrigel invasion, colony formation, proliferation, apoptosis, Western blotting, and in vivo tumorigenesis and metastasis assays were employed to evaluate the roles of circTADA2A, miR-203a-3p and CREB3. RESULTS: Our findings demonstrated that circTADA2A was highly expressed in both OS tissue and cell lines, and circTADA2A inhibition attenuated the migration, invasion and proliferation of OS cells in vitro as well as tumorigenesis and metastasis in vivo. A mechanistic study revealed that circTADA2A could readily sponge miR-203a-3p to upregulate the expression of CREB3, which was identified as a driver gene in OS. Furthermore, miR-203a-3p inhibition or CREB3 overexpression could reverse the circTADA2A silencing-induced impairment of malignant tumor behavior. CONCLUSIONS: CircTADA2A functions as a tumor promoter in OS to increase malignant tumor behavior through the miR-203a-3p/CREB3 axis, which could be a novel target for OS therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sun, Q., Yu, R., Wang, C., Yao, J., & Zhang, L. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01287-8 · Cited by 24
RetractedCircular RNAs are a large class of animal RNAs with regulatory potency
Memczak, S., Jens, M., Elefsinioti, A., Torti, F., Krueger, J., Rybak, A., Maier, L., Mackowiak, S. D., Gregersen, L. H., Munschauer, M., et al. (2013) · Nature · doi:10.1038/nature11928 · Cited by 7,990
Circular RNAs are abundant, conserved, and associated with ALU repeats
Jeck, W. R., Sorrentino, J. A., Wang, K., Slevin, M. K., Burd, C. E., Liu, J., Marzluff, W. F., & Sharpless, N. E. (2013) · RNA · doi:10.1261/rna.035667.112 · Cited by 4,388
Detecting and characterizing circular RNAs
Jeck, W. R., & Sharpless, N. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2890 · Cited by 2,702
Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.776 · Cited by 2,393
Expanded identification and characterization of mammalian circular RNAs
Guo, J. U., Agarwal, V., Guo, H., & Bartel, D. P. (2014) · Genome biology · doi:10.1186/preaccept-1176565312639289 · Cited by 1,585
Circular RNAs: analysis, expression and potential functions
Barrett, S. P., & Salzman, J. (2016) · Development · doi:10.1242/dev.128074 · Cited by 859
Serrano-Gomez, S. J., Maziveyi, M., & Alahari, S. K. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0502-x · Cited by 814
Circular RNAs: Promising Biomarkers for Human Diseases
Zhang, Z., Yang, T., & Xiao, J. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.07.036 · Cited by 775
A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis
Zhang, M., Huang, N., Yang, X., Luo, J., Yan, S., Xiao, F., Chen, W., Gao, X., Zhao, K., Zhou, H., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0019-9 · Cited by 721
Hou, J., Lin, L., Zhou, W., Wang, Z., Ding, G., Dong, Q., Qin, L., Wu, X., Zheng, Y., Yang, Y., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.001 · Cited by 690
Primary bone osteosarcoma in the pediatric age: State of the art
Longhi, A., Errani, C., De Paolis, M., Mercuri, M., & Bacci, G. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.05.005 · Cited by 631
Circ HIPK 3 sponges miR‐558 to suppress heparanase expression in bladder cancer cells
Li, Y., Zheng, F., Xiao, X., Xie, F., Tao, D., Huang, C., Liu, D., Wang, M., Wang, L., Zeng, F., et al. (2017) · EMBO reports · doi:10.15252/embr.201643581 · Cited by 557
Zhang, J., Liu, H., Hou, L., Wang, G., Zhang, R., Huang, Y., Chen, X., & Zhu, J. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0719-3 · Cited by 517
Self-citationAn emerging function of circRNA-miRNAs-mRNA axis in human diseases
Rong, D., Sun, H., Li, Z., Liu, S., Dong, C., Fu, K., Tang, W., & Cao, H. (2017) · Oncotarget · doi:10.18632/oncotarget.19154 · Cited by 516
lncRNA Directs Cooperative Epigenetic Regulation Downstream of Chemokine Signals
Xing, Z., Lin, A., Li, C., Liang, K., Wang, S., Liu, Y., Park, P. K., Qin, L., Wei, Y., Hawke, D. H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.10.013 · Cited by 447
Noone, A.-M., Cronin, K. A., Altekruse, S. F., Howlader, N., Lewis, D. R., Petkov, V. I., & Penberthy, L. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0520 · Cited by 427
Circular RNA participates in the carcinogenesis and the malignant behavior of cancer
Zhao, Z.-J., & Shen, J. (2017) · RNA Biology · doi:10.1080/15476286.2015.1122162 · Cited by 425
Yuan, S., Wang, J., Yang, F., Tao, Q., Zhang, J., Wang, L., Yang, Y., Liu, H., Wang, Z., Xu, Q., et al. (2016) · Hepatology · doi:10.1002/hep.27893 · Cited by 404
Self-citationA circular RNA promotes tumorigenesis by inducing c-myc nuclear translocation
Yang, Q., Du, W. W., Wu, N., Yang, W., Awan, F. M., Fang, L., Ma, J., Li, X., Zeng, Y., Yang, Z., et al. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.86 · Cited by 329
Self-citationCircNT5E Acts as a Sponge of miR-422a to Promote Glioblastoma Tumorigenesis
Wang, R., Zhang, S., Chen, X., Li, N., Li, J., Jia, R., Pan, Y., & Liang, H. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0532 · Cited by 298
The Circular RNA circPRKCI Promotes Tumor Growth in Lung Adenocarcinoma
Qiu, M., Xia, W., Chen, R., Wang, S., Xu, Y., Ma, Z., Xu, W., Zhang, E., Wang, J., Fang, T., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2808 · Cited by 285
Self-citationCircular RNA BCRC-3 suppresses bladder cancer proliferation through miR-182-5p/p27 axis
Xie, F., Li, Y., Wang, M., Huang, C., Tao, D., Zheng, F., Zhang, H., Zeng, F., Xiao, X., & Jiang, G. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0892-z · Cited by 273
Future directions in the treatment of osteosarcoma
Bishop, M. W., Janeway, K. A., & Gorlick, R. (2016) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000298 · Cited by 268
Function and clinical significance of circRNAs in solid tumors
Geng, Y., Jiang, J., & Wu, C. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0643-z · Cited by 263
A central role for cadherin signaling in cancer
Kourtidis, A., Lu, R., Pence, L. J., & Anastasiadis, P. Z. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.04.006 · Cited by 250
Cadherins and the tumour progression: is it all in a switch?
Cavallaro, U., Schaffhauser, B., & Christofori, G. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00759-5 · Cited by 201
Candau, R., Moore, P. A., Wang, L., Barlev, N., Ying, C. Y., Rosen, C. A., & Berger, S. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.2.593 · Cited by 186
Lu, R., Yang, P., O’Hare, P., & Misra, V. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5117 · Cited by 175
Macara, I. G., Guyer, R. A., Richardson, G. M., Huo, Y., & Ahmed, S. M. (2014) · Current Biology · doi:10.1016/j.cub.2014.06.068 · Cited by 166
CircIRAK3 sponges miR-3607 to facilitate breast cancer metastasis
Wu, J., Jiang, Z., Chen, C., Hu, Q., Fu, Z., Chen, J., Wang, Z., Wang, Q., Li, A., Marks, J. R., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.05.033 · Cited by 164
Self-citationEmerging function and potential diagnostic value of circular RNAs in cancer
Cui, X., Wang, J., Guo, Z., Li, M., Li, M., Liu, S., Liu, H., Li, W., Yin, X., Tao, J., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0877-y · Cited by 162
Self-citationCircular RNAs and their associations with breast cancer subtypes
Nair, A. A., Niu, N., Tang, X., Thompson, K. J., Wang, L., Kocher, J.-P., Subramanian, S., & Kalari, K. R. (2016) · Oncotarget · doi:10.18632/oncotarget.13134 · Cited by 161
Wei, C., Zhu, M.-X., Lu, N., Liu, J., Yang, Y., Zhang, Y., Shi, Y., Feng, Z., Li, J., Qi, F., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01191-9 · Cited by 156
Liu, H., Liu, Y., Bian, Z., Zhang, J., Zhang, R., Chen, X., Huang, Y., Wang, Y., & Zhu, J. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0902-1 · Cited by 145
Raggo, C., Rapin, N., Stirling, J., Gobeil, P., Smith-Windsor, E., O'Hare, P., & Misra, V. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.16.5639-5649.2002 · Cited by 133
Microarray Expression Profile and Functional Analysis of Circular RNAs in Osteosarcoma
Liu, W., Zhang, J., Zou, C., Xie, X., Wang, Y., Wang, B., Zhao, Z., Tu, J., Wang, X., Li, H., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000481650 · Cited by 128
Novel molecular insights and new therapeutic strategies in osteosarcoma
Otoukesh, B., Boddouhi, B., Moghtadaei, M., Kaghazian, P., & Kaghazian, M. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0654-4 · Cited by 98
A CREB3-regulated ER–Golgi trafficking signature promotes metastatic progression in breast cancer
Howley, B. V., Link, L. A., Grelet, S., El-Sabban, M., & Howe, P. H. (2017) · Oncogene · doi:10.1038/s41388-017-0023-0 · Cited by 80
Shen, S., Huang, K., Wu, Y., Ma, Y., Wang, J., Qin, F., & Ma, J. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.08.005 · Cited by 74
Self-citationLi, S., Weng, J., Song, F., Li, L., Xiao, C. W., Yang, W., Zhu, Z., & Xu, J. (2019) · Cell Death and Disease · doi:10.1038/s41419-020-2616-8 · Cited by 58
c-Jun-N-terminal phosphorylation regulates DNMT1 expression and genome wide methylation in gliomas
Heiland, D. H., Ferrarese, R., Claus, R., Dai, F., Masilamani, A. P., Kling, E., Weyerbrock, A., Kling, T., Nelander, S., & Carro, M. S. (2016) · Oncotarget · doi:10.18632/oncotarget.14330 · Cited by 42
Zhang, Y., Xu, M., Zhang, X., Chu, F., & Zhou, T. (2018) · Oncology Letters · doi:10.3892/ol.2018.8293 · Cited by 42
Shen, S., Zhou, M., Huang, K., Wu, Y., Ma, Y., Wang, J., Ma, J., & Fan, S. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.441 · Cited by 35
Self-citationTherapeutic Potential of Circular RNAs in Osteosarcoma
Wan, B., Hu, H., Wang, R., Liu, W., & Chen, D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00370 · Cited by 34
Huang, J., Zhang, L., Liu, W., Liao, Q., Shi, T., Xiao, L., Hu, F., & Qiu, X. (2012) · Histochemistry and Cell Biology · doi:10.1007/s00418-012-0932-5 · Cited by 28
Kim, Y. S., Kim, J., Jang, S.-W., & Ko, J. (2014) · Oncogene · doi:10.1038/onc.2013.538 · Cited by 25
Zhang, L., Man, Q., Liu, J., Zhong, W., Zheng, Y., Zhao, Y., & Liu, B. (2018) · Histopathology · doi:10.1111/his.13705 · Cited by 20
Park, E., Kang, H., Kim, J., & Ko, J. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356658 · Cited by 13
Cited by
Zhang, P.-F., Pei, X., Li, K.-S., Jin, L.-N., Wang, F., Wu, J., & Zhang, X.-M. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1111-2 · Cited by 253
Metadata
- Authors
- Wu, Y., Xie, Z., Chen, J., Chen, J., Ni, W., Ma, Y., Huang, K., Wang, G., Wang, J., Ma, J., Shen, S., & Fan, S.
- Venue
- Molecular Cancer
- Published
- 2019-04-02
- Volume
- 18
- Issue
- 1
- Pages
- 73-73
- ISSN
- 1476-4598 (ISSN-L)
- OpenAlex
- W2942868969
- Cited by
- 260
- References
- 49
- FWCI
- 13.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.